The pharmaceutical industry's (often misunderstood) role in bringing novel therapies to cancer patients. Guest: David Schenkein, MD, General Partner at GV, Executive Chairman of Agios Pharmaceuticals and Adjunct Attending Physician in Hematology at Tufts Medical Center. Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.
